Supportive Care and Symptom Management Clinical Trials

Titlesort descending Intervention NCT ID Sponsor Status
Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In... metformin hydrochloride, placebo NCT01905046 Alliance for Clinical Trials in Oncology Active, not recruiting
Methylphenidate and Exercise in Reducing Cancer-Related Fatigue in Patients With Prostate Cancer Exercise Intervention, Methylphenidate, Placebo, Quality-of-Life Assessment, Questionnaire Administration, Stretching NCT03772834 M.D. Anderson Cancer Center Recruiting
Mobile Health and Social Media Physical Activity Intervention Among Adolescent and Young Adult... Educational Intervention, FitBit, Goal Setting, Health Promotion and Education, Media Intervention, Telephone-Based Intervention NCT04089358 Children's Oncology Group Recruiting
MRI and Mammography Before Surgery in Patients With Stage I-II Breast Cancer Breast surgery, Magnetic resonance imaging, Mammography NCT01805076 Alliance for Clinical Trials in Oncology Active, not recruiting
Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer NCT03998202 Wake Forest University Health Sciences Recruiting
Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer Laboratory Biomarker Analysis, Naloxegol, Placebo, Quality-of-Life Assessment NCT03087708 Alliance for Clinical Trials in Oncology Active, not recruiting
Netupitant/Palonosetron Hydrochloride and Dexamethasone With or Without Prochlorperazine or... Dexamethasone, Laboratory Biomarker Analysis, Netupitant/Palonosetron Hydrochloride, Olanzapine, Placebo, Prochlorperazine, Quality-of-Life Assessment NCT03367572 University of Rochester NCORP Research Base Recruiting
Neuropsychological and Behavioral Testing in Younger Patients With Cancer Cognitive Assessment, Quality-of-Life Assessment NCT00772200 Children's Oncology Group Recruiting
New Assessment System in Measuring Symptom Distress in Cancer Patients Interview, Quality-of-Life Assessment, Questionnaire Administration NCT00505245 M.D. Anderson Cancer Center Recruiting
Nilotinib in Preventing Paclitaxel-Induced Peripheral Neuropathy in Patients With Stage I-III... Nilotinib, Nilotinib Hydrochloride Monohydrate, Paclitaxel, Placebo, Questionnaire Administration NCT04205903 Ohio State University Comprehensive Cancer Center Recruiting

Pages